Advertisement

Related Videos

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Welcome and Introduction to Vi3C

Advertisement

Advertisement




May
28
Today In Oncology
FDA Approves Durvalumab Plus BCG for High-Risk NMIBC
Local Radiotherapy May Help Control Oligometastatic Breast Cancer
TAILORx and RxPONDER Trials Shift to a Discovery Platform
Radiotherapy for Prostate Cancer: HERMES Trial Compares Two and Five Fractions
BPDCN FDA Approves Pivekimab Sunirine-pvzy
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo